Recessive MYH7-related myopathy in two families.


Journal

Neuromuscular disorders : NMD
ISSN: 1873-2364
Titre abrégé: Neuromuscul Disord
Pays: England
ID NLM: 9111470

Informations de publication

Date de publication:
06 2019
Historique:
received: 06 02 2019
revised: 02 04 2019
accepted: 05 04 2019
pubmed: 28 5 2019
medline: 4 8 2020
entrez: 28 5 2019
Statut: ppublish

Résumé

Myopathies due to recessive MYH7 mutations are exceedingly rare, reported in only two families to date. We describe three patients from two families (from Australia and the UK) with a myopathy caused by recessive mutations in MYH7. The Australian family was homozygous for a c.5134C > T, p.Arg1712Trp mutation, whilst the UK patient was compound heterozygous for a truncating (c.4699C > T; p.Gln1567*) and a missense variant (c.4664A > G; p.Glu1555Gly). All three patients shared key clinical features, including infancy/childhood onset, pronounced axial/proximal weakness, spinal rigidity, severe scoliosis, and normal cardiac function. There was progressive respiratory impairment necessitating non-invasive ventilation despite preserved ambulation, a combination of features often seen in SEPN1- or NEB-related myopathies. On biopsy, the Australian proband showed classical myosin storage myopathy features, while the UK patient showed multi-minicore like areas. To establish pathogenicity of the Arg1712Trp mutation, we expressed mutant MYH7 protein in COS-7 cells, observing abnormal mutant myosin aggregation compared to wild-type. We describe skinned myofiber studies of patient muscle and hypertrophy of type II myofibers, which may be a compensatory mechanism. In summary, we have expanded the phenotype of ultra-rare recessive MYH7 disease, and provide novel insights into associated changes in muscle physiology.

Identifiants

pubmed: 31130376
pii: S0960-8966(19)30061-6
doi: 10.1016/j.nmd.2019.04.002
pii:
doi:

Substances chimiques

MYH7 protein, human 0
Cardiac Myosins EC 3.6.1.-
Myosin Heavy Chains EC 3.6.4.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

456-467

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Sarah J Beecroft (SJ)

Centre for Medical Research University of Western Australia, Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, Western Australia 6009, Australia. Electronic address: sarah.beecroft@uwa.edu.au.

Martijn van de Locht (M)

Physiology, VU University Medical Center, Netherlands.

Josine M de Winter (JM)

Physiology, VU University Medical Center, Netherlands.

Coen A Ottenheijm (CA)

Physiology, VU University Medical Center, Netherlands.

Caroline A Sewry (CA)

Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.

Shehla Mohammed (S)

Department of Clinical Genetics, Guy's and St Thomas' Hospital, London SE1 7EH, UK.

Monique M Ryan (MM)

Murdoch Children's Research Institute, Melbourne, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Australia; Department of Neurology, The Royal Children's Hospital, Melbourne, Australia.

Ian R Woodcock (IR)

Department of Neurology, The Royal Children's Hospital, Melbourne, Australia.

Lauren Sanders (L)

Department of Medicine, Southern Clinical School, Monash University, Melbourne, Australia.

Rebecca Gooding (R)

Neurogenetics Unit, Department of Diagnostic Genomics, PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, Australia.

Mark R Davis (MR)

Neurogenetics Unit, Department of Diagnostic Genomics, PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, Australia.

Emily C Oates (EC)

School of Biotechnology & Biomolecular Sciences, The University of New South Wales, Sydney, Australia.

Nigel G Laing (NG)

Centre for Medical Research University of Western Australia, Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, Western Australia 6009, Australia; Neurogenetics Unit, Department of Diagnostic Genomics, PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, Australia.

Gianina Ravenscroft (G)

Centre for Medical Research University of Western Australia, Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, Western Australia 6009, Australia.

Catriona A McLean (CA)

Department of Anatomical Pathology, Alfred Hospital, Melbourne, Australia; Faculty of Medicine Nursing and Health Sciences, Monash University, Melbourne, Australia.

Heinz Jungbluth (H)

Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's&St Thomas' Hospital NHS Foundation Trust, London, UK; Randall Division of Cell and Molecular Biophysics, Muscle Signaling Section, King's College, London, UK; Department of Clinical and Basic Neuroscience, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH